首页> 外文OA文献 >Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs

【2h】

Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs

机译：用抗PD-1 / Pd-L1 ABS处理非小细胞肺癌患者超前疾病的免疫学特征

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kyung Hwan Kim; Joon Young Hur; Jiae Koh; Jinhyun Cho; Bo Mi Ku; June Young Koh; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Keunchil Park; Myung-Ju Ahn; Eui-Cheol Shin;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. MA 10.11 Hyperprogressive Disease (HPD) Is Frequent in Non-Small Cell Lung Cancer (NSCLC) Patients (Pts) Treated with Anti PD1/PD-L1 Agents (IO) [J] . R. Ferrara, C. Caramella, M. Texier, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：MA 10.11超出疾病（HPD）在用抗PD1 / PD-L1剂（IO）处理的非小细胞肺癌（NSCLC）患者（PTS）中经常出现
2. Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1 [J] . Champiat Stephane, Dercle Laurent, Ammari Samy, Clinical cancer research: an official journal of the American Association for Cancer Research . 2017,第8期

机译：高助剂疾病是抗PD-1 / PD-L1处理的癌症患者的新进展模式
3. Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti-PD-1/PD-L1 Antibodies [J] . Shukuya Takehito, Mori Keita, Amann Joseph M., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2016,第11期

机译：通过抗PD-1 / Pd-L1抗体治疗的先进非小细胞肺癌患者的整体存活与反应或无进展生存的关系
4. IMPROVING PREDICTION OF SURVIVAL USING CT-BASED TUMOR CHARACTERISTICS IN PATIENTS TREATED FOR METASTATIC NON-SMALL CELL LUNG CANCER [C] . WALKER H. LAND JR., ALAN LITWIN, DAN MARGOLIS, Artificial Neural Networks in Engineering Conference . 2010

机译：基于CT基肿瘤特征改善对转移性非小细胞肺癌的患者的肿瘤特征预测
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs [O] . Kyung Hwan Kim, Joon Young Hur, Jiae Koh, 2020

机译：用抗PD-1 / Pd-L1 ABS处理非小细胞肺癌患者超前疾病的免疫学特征
7. EP1.01-55 Neoantigen Deletion Leads to Hyperprogressive Disease (HPD) in Non-Small Cell Lung Cancer (NSCLC) Treated with PD-1/PD-L1 Inhibitors [O] . D. Wu, X. Hong, Y. Liu, 2019

机译：EP1.01-55 Neoantigen缺失导致用PD-1 / Pd-L1抑制剂处理的非小细胞肺癌（NSCLC）中的超前疾病（HPD）

Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs

著录项

引文网络

相似文献

相关主题

期刊订阅